期刊
FRONTIERS IN IMMUNOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.761890
关键词
transcriptomics; inflammatory skin diseases; RNA-Seq; bioinformatics; atopic dermatitis; psoriasis
类别
资金
- Shanghai General Hospital Startup Funding [02.06.01.20.06, 02.06.02.21.01]
Inflammatory skin diseases are caused by disorders in the skin's defense system, resulting in recurrent skin lesions and intense itching that impact life quality. Transcriptomic profiling helps uncover molecular factors of typical inflammatory skin diseases, offering guidance for improved diagnosis and treatment strategies. High-throughput transcriptomics data provides unprecedented insights into the complex pathophysiology of these diseases.
Inflammatory skin diseases are induced by disorders of the host defense system of the skin, which is composed of a barrier, innate and acquired immunity, as well as the cutaneous microbiome. These disorders are characterized by recurrent cutaneous lesions and intense itch, which seriously affecting life quality of people across all ages and ethnicities. To elucidate molecular factors for typical inflammatory skin diseases (such as psoriasis and atopic dermatitis), transcriptomic profiling assays have been largely performed. Additionally, single-cell RNA sequencing (scRNA-seq) as well as spatial transcriptomic profiling have revealed multiple potential translational targets and offered guides to improve diagnosis and treatment strategies for inflammatory skin diseases. High-throughput transcriptomics data has shown unprecedented power to disclose the complex pathophysiology of inflammatory skin diseases. Here, we will summarize discoveries from transcriptomics data and discuss how to maximize the transcriptomics data to propel the development of diagnostic biomarkers and therapeutic targets in inflammatory skin diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据